D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Moupali Das, MD, MPH
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinical Research Puerto Rico
San Juan, Puerto Rico
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Ahf Research Center
Beverly Hills, California, United States
- Anthony Mills Md, Inc
Los Angeles, California, United States
- Kaiser Permanente
Los Angeles, California, United States
- Peter J. Ruane, Md, Inc.
Los Angeles, California, United States
- Orange Coast Medical Group
Newport Beach, California, United States
- Alta Bates Summit Medical Center, East Bay Aids Center
Oakland, California, United States
- Stanford University
Palo Alto, California, United States
- Kaiser Permanente Medical Group
Sacramento, California, United States
- la Playa Medical Group and Clinical Research
San Diego, California, United States
- Kasier Permanente Medical Center
San Francisco, California, United States
- Tpmg--Clinical Trials Unit
San Francisco, California, United States
- Apex Research
Denver, Colorado, United States
- Denver Infectious Disease Consultants, Pllc
Denver, Colorado, United States
- Capital Medical Associates, Pc
Washington D.C., District of Columbia, United States
- Dupont Circle Physician'S Group
Washington D.C., District of Columbia, United States
- Whitman-Walker Health
Washington D.C., District of Columbia, United States
- Gary J. Richmond,m.D.,p.A.
Fort Lauderdale, Florida, United States
- Wohlfeiler, Piperato and Associates, Llc
Miami Beach, Florida, United States
- Idocf/valuhealthmd, Llc
Orlando, Florida, United States
- Orlando Immunology Center
Orlando, Florida, United States
- St. Joseph'S Comprehensive Research Institute
Tampa, Florida, United States
- Infectious Disease Specialists of Atlanta
Decatur, Georgia, United States
- Mercer University Mercer Medicine
Macon, Georgia, United States
- Howard Brown Health Center
Chicago, Illinois, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Community Research Initiative (cri)
Boston, Massachusetts, United States
- Be Well Medical Center
Berkley, Michigan, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Hennepin County Medical Center
Minneapolis, Minnesota, United States
- Central West Clinical Research Inc
St Louis, Missouri, United States
- North Shore University Hospital / Division of Infectious Diseases
Manhasset, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- Id Consultants, P.A.
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University of South Carolina School of Medicine Division of Infectious Disease
Columbia, South Carolina, United States
- Southwest Infectious Disease Clinical Research Inc
Dallas, Texas, United States
- Tarrant County Infectious Disease Associates
Fort Worth, Texas, United States
- Gordon E. Crofoot, Md., Pa
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2012
- Primary completion
- 31 Jan 2013
- Completion
- 28 Feb 2014
- Last update posted
- 11 Apr 2016
- Registered enrollment
- 153
- Registry id
- NCT01565850
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.